| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±5.3% | -4.4% | over-priced |
| 05/21/2026 | ±3.4% | -3.1% | over-priced |
| 02/05/2026 | ±5.3% | -0.2% | over-priced |
| 11/06/2025 | ±3.3% | -2.4% | over-priced |
| 08/07/2025 | ±4.0% | +0.1% | over-priced |
| 05/23/2025 | ±3.0% | -3.2% | under-priced |
| 02/06/2025 | ±3.7% | -0.7% | over-priced |
| 11/05/2024 | ±3.5% | +0.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $0.37 | $1.5B | $230M |
| Q4 FY2026 | — | $1.3B | $144M |
| Q3 FY2026 | $0.06 | $1.2B | $63M |
| Q2 FY2026 | $0.03 | $1.1B | $42M |
MCHP (MCHP) reports in 9 days, with the next report estimated for 11/05/2026. Across the last 8 reports, options priced an average ±4.0% earnings move while the stock actually moved 1.9% on average — the market has systematically over-priced MCHP's earnings risk. Fundamentals into the print: EPS up 511.1% year-over-year, revenue up 38.0%. QuantLogix's live 5-factor engine currently reads MCHP as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →